BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31705190)

  • 1. What is new in pericytomatous, myoid, and myofibroblastic tumors?
    John I; Fritchie KJ
    Virchows Arch; 2020 Jan; 476(1):57-64. PubMed ID: 31705190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myopericytomatosis: Clinicopathologic Analysis of 11 Cases With Molecular Identification of Recurrent PDGFRB Alterations in Myopericytomatosis and Myopericytoma.
    Hung YP; Fletcher CDM
    Am J Surg Pathol; 2017 Aug; 41(8):1034-1044. PubMed ID: 28505006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblastic and myofibroblastic tumors of children: new genetic entities and new ancillary testing.
    Parham DM
    F1000Res; 2018; 7():. PubMed ID: 30613391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel SRF-ICA1L Fusions in Cellular Myoid Neoplasms With Potential For Malignant Behavior.
    Suurmeijer AJ; Dickson BC; Swanson D; Sung YS; Zhang L; Antonescu CR
    Am J Surg Pathol; 2020 Jan; 44(1):55-60. PubMed ID: 31478943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SRF Fusions Other Than With RELA Expand the Molecular Definition of SRF-fused Perivascular Tumors.
    Karanian M; Kelsey A; Paindavoine S; Duc A; Vanacker H; Hook L; Weinbreck N; Delfour C; Minard V; Baillard P; Blay JY; Pissaloux D; Tirode F
    Am J Surg Pathol; 2020 Dec; 44(12):1725-1735. PubMed ID: 33021523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of pericytic neoplasm in the shoulder with a novel DERA-GLI1 gene fusion.
    Nitta Y; Takeda M; Fujii T; Itami H; Tsukamoto S; Honoki K; Ohbayashi C
    Histopathology; 2021 Feb; 78(3):466-469. PubMed ID: 33067875
    [No Abstract]   [Full Text] [Related]  

  • 7. Recurrent Somatic PDGFRB Mutations in Sporadic Infantile/Solitary Adult Myofibromas But Not in Angioleiomyomas and Myopericytomas.
    Agaimy A; Bieg M; Michal M; Geddert H; Märkl B; Seitz J; Moskalev EA; Schlesner M; Metzler M; Hartmann A; Wiemann S; Michal M; Mentzel T; Haller F
    Am J Surg Pathol; 2017 Feb; 41(2):195-203. PubMed ID: 27776010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent SRF-RELA Fusions Define a Novel Subset of Cellular Myofibroma/Myopericytoma: A Potential Diagnostic Pitfall With Sarcomas With Myogenic Differentiation.
    Antonescu CR; Sung YS; Zhang L; Agaram NP; Fletcher CD
    Am J Surg Pathol; 2017 May; 41(5):677-684. PubMed ID: 28248815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinicopathologic features of gastric plexiform fibromyxoma].
    Hu GM; Chen HP; Liu QY; Shi XC; Wu HF; Feng YK; Ren JL; Wang CF
    Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):258-262. PubMed ID: 29690664
    [No Abstract]   [Full Text] [Related]  

  • 10. BRAF V600E is not a consistent feature of myopericytoma.
    Mito JK; Jo VY
    J Cutan Pathol; 2016 Dec; 43(12):1248-1249. PubMed ID: 27870159
    [No Abstract]   [Full Text] [Related]  

  • 11. [Myofibroma/myofibromatosis: a clinicopathologic analysis of 9 cases].
    Fu Y; Guan WY; Wu HY; Wu HY; Fan ZW; Ye Q; Meng FQ
    Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):45-50. PubMed ID: 29325250
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular Alterations in Pediatric Fibroblastic/Myofibroblastic Tumors: An Appraisal of a Next Generation Sequencing Assay in a Retrospective Single Centre Study.
    Slack JC; Bründler MA; Nohr E; McIntyre JB; Kurek KC
    Pediatr Dev Pathol; 2021; 24(5):405-421. PubMed ID: 33970051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Distinct Malignant Epithelioid Neoplasm With GLI1 Gene Rearrangements, Frequent S100 Protein Expression, and Metastatic Potential: Expanding the Spectrum of Pathologic Entities With ACTB/MALAT1/PTCH1-GLI1 Fusions.
    Antonescu CR; Agaram NP; Sung YS; Zhang L; Swanson D; Dickson BC
    Am J Surg Pathol; 2018 Apr; 42(4):553-560. PubMed ID: 29309307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic characterization of perivascular myoid cell neoplasms, using myosin 1B, a newly identified human pericyte marker.
    Meguro S; Akamatsu T; Matsushima S; Kosugi I; Kawasaki H; Arai Y; Baba S; Tsuchida T; Shido Y; Suda T; Iwashita T
    Hum Pathol; 2017 Apr; 62():187-198. PubMed ID: 28088345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Distinctive Genomic and Immunohistochemical Profile for NOTCH3 and PDGFRB in Myofibroma With Diagnostic and Therapeutic Implications.
    Koo SC; Janeway KA; Harris MH; Fryer CJ; Aster JC; Al-Ibraheemi A; Church AJ
    Int J Surg Pathol; 2020 Apr; 28(2):128-137. PubMed ID: 31566039
    [No Abstract]   [Full Text] [Related]  

  • 16. EWSR1-SMAD3-rearranged Fibroblastic Tumor: An Emerging Entity in an Increasingly More Complex Group of Fibroblastic/Myofibroblastic Neoplasms.
    Michal M; Berry RS; Rubin BP; Kilpatrick SE; Agaimy A; Kazakov DV; Steiner P; Ptakova N; Martinek P; Hadravsky L; Michalova K; Szep Z; Michal M
    Am J Surg Pathol; 2018 Oct; 42(10):1325-1333. PubMed ID: 29957732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant receptor tyrosine kinase signaling in lipofibromatosis: a clinicopathological and molecular genetic study of 20 cases.
    Al-Ibraheemi A; Folpe AL; Perez-Atayde AR; Perry K; Hofvander J; Arbajian E; Magnusson L; Nilsson J; Mertens F
    Mod Pathol; 2019 Mar; 32(3):423-434. PubMed ID: 30310176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PDGFRB and NOTCH3 Mutations are Detectable in a Wider Range of Pericytic Tumors, Including Myopericytomas, Angioleiomyomas, Glomus Tumors, and Their Combined Tumors.
    Iwamura R; Komatsu K; Kusano M; Kubo C; Inaba Y; Shiba E; Nawata A; Tajiri R; Matsuyama A; Matoba H; Koga K; Takeda M; Itami H; Hisaoka M
    Mod Pathol; 2023 Mar; 36(3):100070. PubMed ID: 36788105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Childhood fibroblastic and myofibroblastic tumors: a multicenter documentation and review of the literature.
    Kaçar A; Paker I; Orhan D; Poyraz A; Okçu Heper A; Arda N; Boduroğlu E
    Turk Patoloji Derg; 2012; 28(1):24-30. PubMed ID: 22207428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variant of SRF-rearranged myofibroma with a misleading nuclear expression of STAT6 and STAT6 involvement as 3' fusion partner.
    Nihous H; Macagno N; Baud-Massière J; Haffner A; Jouve JL; Gentet JC; Touzery C; Le Loarer F; Bouvier C
    Virchows Arch; 2021 Mar; 478(3):597-603. PubMed ID: 32529351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.